BACKGROUND: Pseudomonas aeruginosa bacteremia is a serious and possibly fatal condition. It is important to determine the likelihood of P. aeruginosa bacteremia when Gram-negative sepsis is suspected in community-onset infection. METHODS: We performed a retrospective cohort study to identify the risk factors for P. aeruginosa infection in community-onset Gram-negative bacteremia. RESULTS: A total of 106 patients with P. aeruginosa bacteremia and a total 508 patients with E. coli bacteremia were included in this study. Factors associated with P. aeruginosa bacteremia in the multivariate analysis included presentation with neutropenia, presentation with septic shock, indwelling central venous catheter, and health-care-associated infection (all P <.05). The 30-day mortality rate was 26.4% in patients with P. aeruginosa and 13.6% in those with E. coli bacteremia (P <.001). Multivariate analysis demonstrated that risk factors for mortality included a P. aeruginosa bacteremia, inappropriate initial antimicrobial therapy, a higher Charlson's weighted index of comorbidity, and a higher Pitt bacteremia score (all P <.05). In addition, urinary tract infection and benign pancreatobiliary disease were found to be protective factors for mortality based on multivariate analysis (all P <.05). CONCLUSIONS: Our data suggest that initial empirical antimicrobial coverage of P. aeruginosa should be seriously considered in patients with neutropenia, presentation with septic shock, indwelling central venous catheter, or health-care-associated infection, when Gram-negative sepsis is suspected in community-onset infection.
BACKGROUND: Pseudomonas aeruginosa bacteremia is a serious and possibly fatal condition. It is important to determine the likelihood of P. aeruginosa bacteremia when Gram-negative sepsis is suspected in community-onset infection. METHODS: We performed a retrospective cohort study to identify the risk factors for P. aeruginosa infection in community-onset Gram-negative bacteremia. RESULTS: A total of 106 patients with P. aeruginosa bacteremia and a total 508 patients with E. coli bacteremia were included in this study. Factors associated with P. aeruginosa bacteremia in the multivariate analysis included presentation with neutropenia, presentation with septic shock, indwelling central venous catheter, and health-care-associated infection (all P <.05). The 30-day mortality rate was 26.4% in patients with P. aeruginosa and 13.6% in those with E. coli bacteremia (P <.001). Multivariate analysis demonstrated that risk factors for mortality included a P. aeruginosa bacteremia, inappropriate initial antimicrobial therapy, a higher Charlson's weighted index of comorbidity, and a higher Pitt bacteremia score (all P <.05). In addition, urinary tract infection and benign pancreatobiliary disease were found to be protective factors for mortality based on multivariate analysis (all P <.05). CONCLUSIONS: Our data suggest that initial empirical antimicrobial coverage of P. aeruginosa should be seriously considered in patients with neutropenia, presentation with septic shock, indwelling central venous catheter, or health-care-associated infection, when Gram-negative sepsis is suspected in community-onset infection.
Authors: Weining Zhao; Ashley R Cross; Caillan Crowe-McAuliffe; Angela Weigert-Munoz; Erika E Csatary; Amy E Solinski; Joanna Krysiak; Joanna B Goldberg; Daniel N Wilson; Eva Medina; William M Wuest; Stephan A Sieber Journal: Angew Chem Int Ed Engl Date: 2019-05-16 Impact factor: 15.336
Authors: Sarah E Cain; Joseph Kohn; P Brandon Bookstaver; Helmut Albrecht; Majdi N Al-Hasan Journal: Antimicrob Agents Chemother Date: 2014-10-27 Impact factor: 5.191
Authors: Elizabeth B Nimmich; P Brandon Bookstaver; Joseph Kohn; Julie Ann Justo; Katie L Hammer; Helmut Albrecht; Majdi N Al-Hasan Journal: Hosp Pharm Date: 2017-07-21
Authors: Phat L Tran; Eric Huynh; Abdul N Hamood; Anselm de Souza; Gregory Schultz; Bernd Liesenfeld; Dilip Mehta; Daniel Webster; Ted W Reid Journal: Int Wound J Date: 2015-12-28 Impact factor: 3.315
Authors: Cheol-In Kang; Jae-Hoon Song; Doo Ryeon Chung; Kyong Ran Peck; Joon-Sup Yeom; Jun Seong Son; Yu Mi Wi Journal: Support Care Cancer Date: 2011-12-23 Impact factor: 3.603
Authors: Mohammed J Al-Jaghbeer; Julie Ann Justo; William Owens; Joseph Kohn; P Brandon Bookstaver; Jennifer Hucks; Majdi N Al-Hasan Journal: Infection Date: 2018-05-11 Impact factor: 3.553
Authors: Phat L Tran; Adrienne A Hammond; Thomas Mosley; Janette Cortez; Tracy Gray; Jane A Colmer-Hamood; Mayank Shashtri; Julian E Spallholz; Abdul N Hamood; Ted W Reid Journal: Appl Environ Microbiol Date: 2009-04-03 Impact factor: 4.792